GCLP Accreditation for Epistem's Biomarker Division
.jpg "Epistem - Epistem's Biomarker Division")
Recent GCLP accreditation enables Epistem's Biomarker Division to support the later clinical phases of drug development. For further information please click here.
Latest News
| Oncology |
| Inflammatory Bowel Disease |
| Oncology Supportive Care (Mucositis) |
| Dermatology |
| Histology and Molecular Services |
| Scientific Overview |
| Discovery Platform |
| Emerging Protein Therapeutic Pipeline |
| Partnerships |
| Click here to go visit our Biomarker microsite |
| Investor Information |
| Company Profile |
| Shareholder Information |
| Share Price Information |
| RNS Announcements |
| Directors |
| Company Reports |
| Constitutional Documents |
| Corporate Governance |
| Advisors |
| Press Releases |
| Events |
| How to find us |
Recent GCLP accreditation enables Epistem's Biomarker Division to support the later clinical phases of drug development. For further information please click here.